Intuitive Surgical shows strong growth and a robust business model, making it an attractive investment despite its high valuation.
Source Post
Intuitive Surgical: Time to Buy this S&P 500 Heavyweight?
Playing FTSEApr 26, 2026
The creator discusses Intuitive Surgical (ISRG), highlighting its strong recent earnings report with significant year-over-year growth in revenue and EPS, driven by strong performance across all business segments and increased system placements. The company's "razor and blade" model, particularly its recurring revenue from instruments and accessories, is noted as a key strength. Despite a historically high valuation, the stock's performance post-earnings suggests continued investor interest.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.